The latest European guidelines suggested that the PNPLA3 rs738409 C > G gene polymorphism has been associated with an increased HCC risk and might provide patient risk stratification for tailored HCC surveillance in NAFLD. The gene discussed is PNPLA3; the disease is hepatocellular carcinoma.